Clinical trial
Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine
NCT00419133 · International Vaccine Institute, Other · Completed
Key facts
| NCT number | NCT00419133 |
|---|---|
| Title | Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine |
| Official title | Immune Responses Following One Versus Two Doses of Killed Oral Cholera Vaccine in Eastern Kolkata, West Bengal, India |
| Lead sponsor | International Vaccine Institute, Other |
| Collaborators | National Institute of Cholera and Enteric Diseases, India Shantha Biotechnics Limited Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cholera, Diarrhea, Vibrio Infections |
| Intervention type | Biological |
| Interventions | Killed bivalent whole cell oral cholera vaccine, Heat Killed E. coli Placebo |
| Enrollment | 160 |
| Start date | Jun 1, 2007 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jan 8, 2007 |
| Last update posted | Dec 7, 2009 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: